Evercore Inc. (EVR) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US29977A1051
Evercore Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 3.88 bn USD |
| EBIT | 818.08 m USD |
| Net income | 591.92 m USD |
| Diluted EPS – continuing operations | 14.05 USD |
Full history since 2003, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Evercore Inc.
Evercore Inc., together with its subsidiaries, operates as an independent investment banking firm in the Americas, Europe, Middle East, Africa, and Asia-Pacific. The company operates through two segments, Investment Banking & Equities, and Investment Management. The Investment Banking & Equities segment offers strategic advisory services, such as mergers, and acquisitions, strategic, defense, and shareholder advisory, special committee assignments, and real estate strategic advisory; private capital advisory and fundraising, market risk management and hedging, private capital markets and debt advisory, liability management and restructuring, and equity capital markets execution and advisory services; and research, sales, and trading professionals services on a content-led platform to its institutional investor clients. The Investment Management segment provides wealth management services to high-net-worth individuals, foundations, and endowments. The company was formerly known as Evercore Partners Inc. and changed its name to Evercore Inc. in August 2017. Evercore Inc. was founded in 1995 and is headquartered in New York, New York.
More stocks
- Sinoma Science & Technology Co Ltd (002080.SZ)
- AST SpaceMobile, Inc. (ASTS)
- Paycom Software, Inc. (PAYC)
- Biwin Storage Technology Co. Ltd. A (688525.SS)
- IES Holdings, Inc. (IESC)
- FIRST HORIZON CORP (FHN)
- QXO, Inc. (QXO)
- Guangdong Haid Group Co Ltd (002311.SZ)
- Aier Eye Hospital Group (300015.SZ)
- WH Group Ltd (288.HK)
- Allwyn AG (ALWN.AT)
- Pharmaron Beijing Co Ltd (300759.SZ)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.